These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8998156

  • 1. Evaluation of fulminant hepatic failure by scintigraphy with technetium-99m-GSA.
    Shiomi S, Kuroki T, Kuriyama M, Takeda T, Nishiguchi S, Nakajima S, Tanaka T, Ochi H.
    J Nucl Med; 1997 Jan; 38(1):79-82. PubMed ID: 8998156
    [Abstract] [Full Text] [Related]

  • 2. Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver.
    Sasaki N, Shiomi S, Iwata Y, Nishiguchi S, Kuroki T, Kawabe J, Ochi H.
    J Nucl Med; 1999 Oct; 40(10):1652-6. PubMed ID: 10520705
    [Abstract] [Full Text] [Related]

  • 3. Clinical need for both scintigraphy with technetium-99m GSA and per-rectal portal scintigraphy in some patients with chronic liver disease.
    Shiomi S, Iwata Y, Sasaki N, Kurooka H, Tamori A, Habu D, Takeda T, Nishiguchi S, Kuroki T, Ochi H.
    Ann Nucl Med; 1999 Aug; 13(4):241-5. PubMed ID: 10510880
    [Abstract] [Full Text] [Related]

  • 4. Fulminant hepatic failure monitored by technetium-99m-DTPA-galactosyl-human serum albumin scintigraphy.
    Shiomi S, Kuroki T, Enomoto M, Ueda T, Masaki K, Ikeoka N, Takeda T, Kobayashi K, Ochi H.
    J Nucl Med; 1996 Apr; 37(4):641-3. PubMed ID: 8691258
    [Abstract] [Full Text] [Related]

  • 5. Use of scintigraphy with 99mtechnetium galactosyl human serum albumin for staging of primary biliary cirrhosis and assessment of prognosis.
    Shiomi S, Sasaki N, Tamori A, Habu D, Takeda T, Nishiguchi S, Kuroki T, Kawabe J, Ochi H.
    J Gastroenterol Hepatol; 1999 Jun; 14(6):566-71. PubMed ID: 10385066
    [Abstract] [Full Text] [Related]

  • 6. [Clinical application of asialoglycoprotein receptor-mediated liver scintigraphy using 99mTc-DTPA-galactosyl-human serum albumin].
    Ha-Kawa SK, Nakanishi Y, Kojima M, Tanaka Y, Kitagawa S, Kubota Y, Inoue K, Ikekubo K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Dec 25; 51(12):1489-97. PubMed ID: 1792157
    [Abstract] [Full Text] [Related]

  • 7. Tc-99m GSA scintigraphy within the first 3 days after admission as an early predictor of outcome in severe acute liver injury.
    Suzuki Y, Kakisaka K, Sato T, Mikami R, Abe H, Sasaki T, Takikawa Y.
    Sci Rep; 2021 Jun 15; 11(1):12518. PubMed ID: 34131241
    [Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of hepatic scintigraphy using 99mTc-GSA].
    Ishii K, Nishiyama S, Nishimaki H, Tadokoro K, Ikeda T, Matsubayashi T, Ishii K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jun 25; 52(6):818-29. PubMed ID: 1641314
    [Abstract] [Full Text] [Related]

  • 9. Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT.
    Hwang EH, Taki J, Shuke N, Nakajima K, Kinuya S, Konishi S, Michigishi T, Aburano T, Tonami N.
    J Nucl Med; 1999 Oct 25; 40(10):1644-51. PubMed ID: 10520704
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of hepatic function with (99m)Tc-galactosylated serum albumin scintigraphy in patients with malaria: comparison with (99m)Tc-colloid scintigraphy and liver ultrasonography.
    Lee SW, Lee J, Lee DY, Chun KA, Ahn BC, Kang YM, Lee K.
    Nucl Med Commun; 2007 Feb 25; 28(2):95-9. PubMed ID: 17198349
    [Abstract] [Full Text] [Related]

  • 11. Scintigraphic study of regenerative nodules due to fulminant hepatic failure.
    Watanabe T, Kondo M, Hirasa M, Shirane H, Okabe Y, Ibuki Y, Tomita S, Orino A, Todo A, Wakatsuki Y, Chiba T, Kudo M.
    J Gastroenterol; 2003 Feb 25; 38(7):695-9. PubMed ID: 12898364
    [Abstract] [Full Text] [Related]

  • 12. A simplified method for the quantitative analysis of 99Tc(m)-GSA liver scintigraphy using spectral analysis.
    Murase K, Tsuda T, Mochizuki T, Ikezoe J.
    Nucl Med Commun; 1998 Mar 25; 19(3):219-27. PubMed ID: 9625496
    [Abstract] [Full Text] [Related]

  • 13. [A study of acquisition time using compartment analysis with 99mTc-GSA liver scintigraphy].
    Shinohara H, Niio Y, Hasebe S, Matuoka S, Oobuchi M, Higashi TS, Yamada M, Takagi T, Takizawa K, Suzuki S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Nov 25; 55(14):972-9. PubMed ID: 8570394
    [Abstract] [Full Text] [Related]

  • 14. [Phase II clinical study on 99mTc-GSA, a new agent for functional imaging of the liver].
    Torizuka K, Ha-Kawa SK, Kudo M, Kitagawa S, Kubota Y, Tanaka Y, Hino M, Ikekubo K.
    Kaku Igaku; 1992 Jan 25; 29(1):85-95. PubMed ID: 1578824
    [Abstract] [Full Text] [Related]

  • 15. Hepatic functional reserve in patients with biliary malignancies: an assessment by technetium 99m galactosyl human serum albumin hepatic scintigraphy.
    Fukunaga K, Todoroki T, Takada Y, Otsuka M, Kawamoto T, Fukao K.
    Int Surg; 1999 Jan 25; 84(3):199-203. PubMed ID: 10533776
    [Abstract] [Full Text] [Related]

  • 16. Technetium-99m-DTPA-galactosyl human serum albumin liver scintigraphy evaluation of regional CT/MRI attenuation/signal intensity differences.
    Akaki S, Mitsumori A, Kanazawa S, Togami I, Takeda Y, Joja I, Hiraki Y.
    J Nucl Med; 1998 Mar 25; 39(3):529-32. PubMed ID: 9529304
    [Abstract] [Full Text] [Related]

  • 17. [Clinical application of 99mTc-DTPA-galactosyl serum albumin in hepatobiliary disease].
    Ohno K, Itoh K, Nagao K, Katoh H, Okushiba T, Satoh M, Tomiyama M, Hiraguchi E, Tanabe T.
    Kaku Igaku; 1993 Feb 25; 30(2):217-24. PubMed ID: 8468807
    [Abstract] [Full Text] [Related]

  • 18. [The utility of quantitative 99mTc-GSA liver scintigraphy in the evaluation of hepatic functional reserve: comparison with 99mTc-PMT and 99mTc-Sn colloid].
    Shuke N, Aburano T, Nakajima K, Yokoyama K, Sun BF, Matsuda H, Muramori A, Michigishi T, Tonami N, Hisada K.
    Kaku Igaku; 1992 May 25; 29(5):573-84. PubMed ID: 1434071
    [Abstract] [Full Text] [Related]

  • 19. A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor.
    Ha-Kawa SK, Tanaka Y.
    J Nucl Med; 1991 Dec 25; 32(12):2233-40. PubMed ID: 1744708
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of usefulness of Tc-99m-GSA liver scintigraphy in chronic liver diseases].
    Fukui H, Kashiwagi T, Kasahara A, Hiramatsu N, Matsunaga T, Oshita M, Goto M, Takei Y, Hayashi N, Kawano S.
    Kaku Igaku; 1991 Nov 25; 28(11):1333-41. PubMed ID: 1770648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.